KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Sunday
Mar132011

2010-019996-32

Friday
Dec172010

NCT01291810

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

Conditions: Crohn's Disease
Sponsors: Neovacs
Phase II

Wednesday
Nov242010

NCT01250470

Survivin Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH (SurVaxM) in Patients with Survivin-Positive Malignant Gliomas

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor
Sponsors: Roswell Park Cancer Institute
Collaborators: NCI, MimiVax
Phase I

Monday
Nov222010

NCT01248273

Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

Conditions: Fallopian Tubes, Ovarian Cancer, Peritoneal Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I

Friday
Nov192010

NCT01245673  

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

Conditions: Multiple Myeloma
Sponsors: Abramson Cancer Center of the University of Pennsylvania
Phase: II 

Thursday
Oct142010

NCT01223235

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, Genentech
Phase n/a 

Wednesday
Aug252010

NCT01189383

IL15 Dendritic Cell Vaccine for Patients With Resected Stage IIIc and Stage IV Melanoma

Conditions: Stage IIIc/IV Melanoma
Sponsors: Baylor Research Institute
Phase I, II

Friday
Jul302010

NCT01174082

Donor Lymphocyte Infusion for Myeloma

Conditions: Myeloma
Sponsors: M.D. Anderson Cancer Center
Phase 2

Tuesday
Jul272010

NCT01171729

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Conditions: Prostatic Cancer
Sponsors: Samsung Medical Center
Phase I, II

Wednesday
Jun092010

NCT01141491